Low-grade cribriform cystadenocarcinoma (LGCCC) is a rare salivary gland tumor characterized by cystic, papillary, and cribriform proliferation that histologically resembles atypical ductal hyperplasia (ADH) and low-grade ductal carcinoma in situ (LG-DCIS) of the breast. Because of its indolent clinical behavior, LGCCC was only recently established as an entity in the 2005 World Health Organization (WHO) classification system. 1 Therefore, preoperative diagnosis using fine-needle aspiration (FNA) is critical for differentiating a diagnosis of LGCCC from other salivary gland tumors to avoid unnecessary treatments, such as chemotherapy and radiotherapy. Because, psammoma bodies are infrequently found in usual FNAs of salivary glands, they can disturb the correct diagnosis. Herein, we present cytologic findings of LGCCC with many psammoma bodies. To the best of our knowledge, this is the third case describing cytologic findings of LGCCCs in salivary glands that involve the parotid gland and the submandibular gland. It is also the first case of LGCCC showing exuberant psammoma bodies.
Low-grade cribriform cystadenocarcinoma (LGCCC) is a rare salivary gland tumor characterized by cystic, papillary, and cribriform proliferation that histologically resembles atypical ductal hyperplasia (ADH) and low-grade ductal carcinoma in situ (LG-DCIS) of the breast. Because of its indolent clinical behavior, LGCCC was only recently established as an entity in the 2005 World Health Organization (WHO) classification system. 1 Therefore, preoperative diagnosis using fine-needle aspiration (FNA) is critical for differentiating a diagnosis of LGCCC from other salivary gland tumors to avoid unnecessary treatments, such as chemotherapy and radiotherapy. Because, psammoma bodies are infrequently found in usual FNAs of salivary glands, they can disturb the correct diagnosis. Herein, we present cytologic findings of LGCCC with many psammoma bodies. To the best of our knowledge, this is the third case describing cytologic findings of LGCCCs in salivary glands that involve the parotid gland and the submandibular gland. It is also the first case of LGCCC showing exuberant psammoma bodies.
CASE REPORT
A 90-year-old man presented with a palpable mass on his left postauricular region that had been present for three years. The mass was hard, fixed, and recently increased in size. These symptoms were not accompanied by pain, tenderness, local hotness, or recent weight loss. The patient was healthy for his age and had an unremarkable medical history.
Magnetic resonance imaging revealed a well-enhanced 5 cm solid mass including a cystic component in the left parotid gland. The margin of the mass was partly ill-defined. Neither regional nor distant metastasis was found on positron emission tomography-computed tomography scan. The initial diagnosis from clinical and radiologic evidence was a metastatic lymph node or a malignant tumor of the parotid gland. FNA of the tumor was performed.
Papanicolaou-stained smears revealed that tumor cells were arranged both in tight clusters and individually dispersed ( 1A). The tumor cells had round or oval nuclei with mild atypia. Most of the tumor cells had fine chromatin without prominent nucleoli, but some had inconspicuous small nucleoli (Fig. 1B) . The cytoplasm was scant in most of the tumor cells, and numerous naked cells were identified (Fig. 1C) . Some tumor cells had a polygonal shape with dense opaque cytoplasm, which suggested squamoid differentiation even though no obvious keratin material was noted (Fig. 1D) , and a few had cytoplasmic vacuoles of various sizes (Fig. 1E ). Cytoplasmic granules were not found. Inflammatory cells, including lymphocytes, neutrophils, and some macrophages were scattered across the background, and characteristically, numerous psammoma bodies were identified throughout the smears. Most psammoma bodies were present in the background and not connected to the tumor cells, but some of them were surrounded by tumor cells (Fig. 1A, inset) . Necrosis, mucin, and myxoid stromal components were not found in the background, and only one mitotic figure was noted. In view of these cytologic findings, we considered the possibility of either a malignant tumor of the parotid gland or a metastatic tumor of some other organs, most likely the thyroid gland. The possibility of a metastatic thyroid carcinoma could not be excluded because of the presence of many psammoma bodies, which are unusual findings in FNA of salivary glands. No other findings suggesting a specific type of thyroid carcinoma were identified, and no intra-thyroidal lesion was found in radiological examination. Therefore, we diagnosed a low-grade malignancy of the parotid gland and recommended complete excision of the mass.
We surgically removed the parotid gland, which measured 8.5 cm×6 cm×5 cm. On a cut section, a tan to gray solid tumor with a cystic area measuring 5.3 cm×4.5 cm×4 cm was seen. It was relatively well demarcated from the surrounding parotid gland but was nonencapsulated. In the cystic area of the tumor, an intracystic papillary-growing pattern was noted ( Fig. 2A) . Microscopically, the tumor was composed of multilocular cystic lumens in the periphery and solid or papillary proliferation of tumor cells with fibrous stroma in the cystic area (Fig. 2B) . The cystic lumens were lined by two or more bland tumor cells. In the intracystic solid area, the tumor cells were arranged in papillary, cribriform, and solid patterns (Fig. 2C) . The cystic lumens were filled with pink secretory materials, including some macrophages. The tumor cells had round to oval nuclei with inconspicuous nuclear atypia and eosinophilic or clear cytoplasm. Mitotic figures were very rare (<1/10 high power fields), and necrosis was absent. Cellular pleomorphisms and prominent nucleoli were not observed, but some small nucleoli were present. Neither perineural nor vascular invasion were present, but focal stromal invasion of the tumor cells into the fibrotic stroma was noted. Numerous psammoma bodies were observed in fibrotic stroma and between the tumor cells (Fig. 2C ). All these microscopic findings in the surgical specimen were similar to the cytologic findings from preoperative FNA. Immunohistochemically, most tumor cells were positive for S-100 protein (Fig. 2D) . Smooth muscle actin (SMA) (Fig. 2E ) and p63 ( Fig. 2F) were positive only in the periphery of the cystic lumens and the rims of papillary, cribriform, and solid tumor cell nests, which suggests intracystic or intraductal growth. The Ki-67 proliferation index was less than 5%. Thyroid transcription factor-1 (TTF-1) and thyroglobulin were negative.
DISCUSSION
LGCCC is a rare salivary gland tumor, and only 38 cases have been reported to date. 2, 3 In 1996, Delgado et al. 4 were the first to define this tumor as a low-grade variant of salivary ductal carcinoma (SDC). They reported 10 cases of SDC showing lowgrade histology and prominent intraductal growth and developed the term low-grade salivary ductal carcinoma (LGSDC) for this tumor. All 10 cases in the Delgado et al. 4 report were tumors that presented in the parotid gland, and none of the patients died from the disease during the follow-up period. Brandwein-Gensler et al. 5 reported 16 more cases of LGSDC in 2004, and all patients in their report had a favorable prognosis as well.
LGCCC came to be regarded as a variant of cystadenocarcinoma by the 2005 WHO classification system 1 and was characterized by a distinct histologic presentation and biological behavior. Most cases in that report were also from tumors that presented in the parotid gland, with the exception of one case that presented in the submandibular gland. Because of its favorable outcome, differentiating LGCCC from other salivary gland tumors at the point of preoperative FNA diagnostics is critical for appropriate treatment decisions. However, it is very difficult to make a differential diagnosis by cytologic findings in the salivary gland, and only two reports, by Nakazawa et al. 6 and Obokata et al. 3 have described the cytologic features of LGCCC.
LGCCC has characteristic histologic features that consist of single or multiple cysts with adjacent intraductal proliferation. The tumor cells are bland and are typically arranged in a cribriform or papillary pattern. Focal invasion of the tumor cells into the surrounding stroma can be seen, but perineural invasion, vascular invasion, nuclear pleomorphisms, mitotic figures, and necrosis are usually absent. The tumor cells are diffusely positive for S-100 proteins, and myoepithelial markers are positive only along the rim of cystic spaces. 1, 2 Based on the histologic findings, LGCCC shares some similar features with several salivary gland tumors including conventional SDC, mucoepidermoid carcinoma (MC), papillary cystic variant of acinic cell carcinoma (PCV-ACC), conventional cystadenocarcinoma, mammary analogue secretory carcinoma (MASC), and polymorphous low-grade adenocarcioma (PLGA). Conventional SDC could be easily excluded from the cytologic diagnosis in the present case, because there was neither a lack of moderate or marked nuclear pleomorphisms nor a necrotic background. MC was also easily ruled out because, despite the fact that the present case exhibited some squamoid cells and cytoplasmic vacuoles, there were no signs of definite intracytoplasmic mucin, intermediate cells, or a mucinous background. Thus, we focused on PCV-ACC, conventional cystadenocarcinoma, MASC, PLGA, and LGCCC during the main differential diagnosis, which was based on the initial FNA. PCV-ACC resembles LGCCC in that PCV-ACC can show papillary-cystic growth patterns and vacuolated cells with clear, cytoplasmic vacuoles. In contrast with the present case, PCV-ACC mostly occurs in young people and is usually negative for S-100 protein. 1 While the sizes of cytoplasmic vacuoles in the present case were variable, those of PCV-ACC are typically more uniform. 2, 6 Conventional cystadenocarcinoma also has a cystic growth pattern with papillary proliferation, but it tends to be more invasive and does not resemble ADH or LGDCIS of the breast. 1 MASC is a newly described tumor of the salivary gland that is associated with ETV6-NTRK3 genetic translocation. 7 Similar to LGCCC, MASC also has papillary and cystic architectural patterns, cytoplasmic vacuoles, and positivity for S-100 protein on immunohistochemical stain. 7, 8 Although we did not perform the appropriate molecular studies to confirm this, the presence of myoepithelial cells around tumor cell nests, which suggests intracystic or intraductal growth, is a feature of LGCCC that helped to distinguish this case from a case of MASC. PLGAs have some similar features to LGCCC, such as cytologic uniformity, papillary-cystic or cribriform growth pattern, and positivity for S-100 protein. 1 However, in contrast to the intracystic or intraductal growth that we observed in the present case, PLGA is characterized by an infiltrative growth pattern with mainly lobular, trabecular, or ductal structures. Papillary-cystic or cribriform growth patterns are typically present in focal areas. The present case can be distinguished from PLGA by its intracystic or intraductal growth which has been shown through immunohistochemical staining to be positive for SMA and p63, to have prominent papillary-cystic and cribriform growth patterns that resemble ADH and LGDCIS of the breast, to have an absence of infiltrative lobular or trabecular tumor cell nests, and to have an absence of perineural invasion, which is common in PLGA.
The presence of numerous psammoma bodies that were widely spread in the tissue smears made the initial diagnosis difficult. Exuberant psammoma bodies are infrequent findings in salivary gland tumors, thus common conditions such as cystic papillary thyroid carcinomas should be ruled out in such circumstances. Negahban et al. 9 reported many psammoma bodies in the FNA of a salivary gland tumor that was diagnosed as PCV-ACC; based on a description of the resected specimen, it was described as a so-called psammoma body-rich papillary cystic acinic cell carcinoma. One report 3 described psammoma bodies as the cytologic findings for a LGCCC diagnosis, but only a few tumor cell clusters in that case contained psammoma bodies. In the present case, numerous psammoma bodies, which were found in the fibrotic stroma and between the tumor cells of the resected specimen, were among the striking features of the FNA smears. No other findings that could suggest a specific type of thyroid carcinoma, such as nuclear clearing, nuclear grooves, intranuclear pseudoinclusions, obvious follicular patterns, or colloid in the background, were identified, and no intra-thyroidal lesion were found. Therefore, for the initial diagnosis, we favored primary malignancy of the salivary gland rather than metastatic thyroid carcinoma. The possibility of metastatic thyroid carcinoma could be completely eliminated by histologic and immunohistochemical findings because we found total negativity for TTF-1 and thyroglobulin after resection of the tumor.
In summary, we report the cytologic findings of an extremely unusual case of LGCCC showing many psammoma bodies in the parotid gland. Differentiating LGCCC from the other salivary gland tumors through preoperative FNA is difficult, but pathologists should consider LGCCC in their differential diagnoses, especially when they encounter low-grade cystic lesions.
The recognition of LGCCC through comprehensive differential diagnosis by FNA is important for appropriate treatment and for predicting patient prognosis.
